COVID-19 vaccine : Experts raise question over hasty approval of Vaccine

New Delhi, 4/1: DCGI has approved two Coronavirus vaccines for emergency use in India. However,  many experts have raised their concerns over the hasty nod to the vaccine. They claimed that the vaccines lack adequate efficacy data.

Previously, the DCGI approved the restricted emergency use of the Oxford COVID-19 vaccine Covisheild and Covaxin of Bharat Biotech.

According to Gagandeep  Kang who is working as a professor in Christian Medical College, Vellore ” I am completely unaware of any data that suggests that Covaxin has any efficacy against any SARS-CoV-2 strain ”

Many other experts have also raised their doubts over the approval of the vaccine . However, Randeep Guleria who is the director of AIIMS referred to Covaxin as the backup vaccine and only be used if it was not clear how efficacious the SII vaccine would be.